ITUS Stock Price, News & Analysis (NASDAQ:ITUS)

$4.05 0.41 (11.26 %)
(As of 01/16/2018 03:57 AM ET)
Previous Close$3.64
Today's Range$3.53 - $4.30
52-Week Range$0.60 - $5.50
Volume2.24 million shs
Average Volume1.37 million shs
Market Capitalization$62.05 million
P/E Ratio-6.33
Dividend YieldN/A
Beta-1.21

About ITUS (NASDAQ:ITUS)

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Instead of seeking to alter or boost the body's immune system and its ability to destroy cancer cells, the Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients.

Receive ITUS News and Ratings via Email

Sign-up to receive the latest news and ratings for ITUS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business Support Services
Sub-IndustryN/A
SectorIndustrials
SymbolNASDAQ:ITUS
CUSIPN/A
Phone+1-310-4845200

Debt

Debt-to-Equity RatioN/A
Current Ratio7.97%
Quick Ratio7.97%

Price-To-Earnings

Trailing P/E Ratio-6.328125
Forward P/E Ratio-6.98
P/E GrowthN/A

Sales & Book Value

Annual Sales$360,000.00
Price / Sales186.86
Cash FlowN/A
Price / CashN/A
Book Value$0.48 per share
Price / Book8.44

Profitability

Trailing EPS($0.64)
Net Income$-5,000,000.00
Net MarginsN/A
Return on Equity-152.26%
Return on Assets-69.94%

Miscellaneous

Employees7
Outstanding Shares16,610,000

ITUS (NASDAQ:ITUS) Frequently Asked Questions

What is ITUS's stock symbol?

ITUS trades on the NASDAQ under the ticker symbol "ITUS."

When will ITUS make its next earnings announcement?

ITUS is scheduled to release their next quarterly earnings announcement on Thursday, January, 18th 2018. View Earnings Estimates for ITUS.

Who are some of ITUS's key competitors?

Who are ITUS's key executives?

ITUS's management team includes the folowing people:

  • Amit Kumar Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 53)
  • Michael J. Catelani, Chief Financial Officer, Chief Operating Officer (Age 50)
  • Arnold Baskies, Director (Age 68)
  • Dale Fox, Independent Director (Age 50)
  • John Monanhan, Independent Director (Age 70)
  • Lewis H. Titterton Jr., Independent Director (Age 73)

How do I buy ITUS stock?

Shares of ITUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ITUS's stock price today?

One share of ITUS stock can currently be purchased for approximately $4.05.

How big of a company is ITUS?

ITUS has a market capitalization of $62.05 million and generates $360,000.00 in revenue each year. The business services provider earns $-5,000,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis. ITUS employs 7 workers across the globe.

How can I contact ITUS?

ITUS's mailing address is 3150 Almaden Expy Ste 250, SAN JOSE, CA 95118-1250, United States. The business services provider can be reached via phone at +1-310-4845200 or via email at [email protected]


MarketBeat Community Rating for ITUS (ITUS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  76
MarketBeat's community ratings are surveys of what our community members think about ITUS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ITUS (NASDAQ:ITUS) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

ITUS (NASDAQ:ITUS) Earnings History and Estimates Chart

Earnings by Quarter for ITUS (NASDAQ:ITUS)

ITUS (NASDAQ ITUS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/18/2018        
9/8/2017Q3 2017($0.12)ViewN/AView Earnings Details
5/26/2017Q2 2017$0.02ViewN/AView Earnings Details
3/15/2017Q1 2017($0.41)ViewN/AView Earnings Details
12/8/2016Q4 2016($0.12)ViewN/AView Earnings Details
8/19/2016Q3 2016($0.13)ViewN/AView Earnings Details
5/20/2016Q2 2016($0.15)ViewN/AView Earnings Details
2/19/2016Q1 2016($0.18)ViewN/AView Earnings Details
12/22/2015Q4 2015($0.14)ViewN/AView Earnings Details
8/18/2015Q3 2015($0.18)ViewN/AView Earnings Details
5/22/2015Q2 2015($0.25)ViewN/AView Earnings Details
3/9/2015Q1 2015$0.50ViewN/AView Earnings Details
1/29/2015Q4 2014($0.25)ViewN/AView Earnings Details
6/16/2014Q2 2014($0.25)ViewN/AView Earnings Details
3/17/2014Q1 2014($0.25)ViewN/AView Earnings Details
1/16/2014Q4 2013($0.25)ViewN/AView Earnings Details
9/16/2013Q3 2013($0.25)ViewN/AView Earnings Details
6/14/2013Q2 2013($0.25)ViewN/AView Earnings Details
3/18/2013Q1 2013($0.25)ViewN/AView Earnings Details
1/29/2013Q4 2012($0.25)ViewN/AView Earnings Details
9/14/2012Q3 2012($0.08)ViewN/AView Earnings Details
6/14/2012Q2 2012($0.10)ViewN/AView Earnings Details
3/16/2012Q1 2012($0.10)ViewN/AView Earnings Details
1/30/2012Q4 2011($0.50)ViewN/AView Earnings Details
9/14/2011Q3 2011($0.25)ViewN/AView Earnings Details
6/14/2011Q2 2011($0.25)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

ITUS (NASDAQ:ITUS) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.58 EPS
Next Year EPS Consensus Estimate: $-0.4 EPS

Dividends

Dividend History for ITUS (NASDAQ:ITUS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ITUS (NASDAQ ITUS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.41%
Institutional Ownership Percentage: 3.65%
Insider Trades by Quarter for ITUS (NASDAQ:ITUS)

ITUS (NASDAQ ITUS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2017Amit KumarDirectorBuy10,000$0.90$9,000.00124,408View SEC Filing  
6/2/2017Amit KumarDirectorBuy10,000$0.88$8,800.00104,908View SEC Filing  
8/24/2016Lewis H Titterton JrDirectorSell210,000$3.10$651,000.00287,437View SEC Filing  
6/30/2016Bruce F JohnsonDirectorBuy4,500$3.26$14,670.00419,119View SEC Filing  
6/27/2016Bruce F JohnsonDirectorBuy400$3.16$1,264.00414,619View SEC Filing  
6/17/2016Bruce F JohnsonDirectorBuy400$3.52$1,408.00414,019View SEC Filing  
6/9/2016Bruce F JohnsonDirectorBuy900$3.31$2,979.00413,819View SEC Filing  
6/8/2016Bruce F JohnsonDirectorBuy500$3.60$1,800.00412,919View SEC Filing  
6/3/2016Bruce F JohnsonDirectorBuy2,000$3.36$6,720.00411,919View SEC Filing  
6/2/2016Henry P HermsCFOSell2,000$3.26$6,520.0024,125View SEC Filing  
5/31/2016Bruce F JohnsonDirectorBuy2,604$3.31$8,619.24407,915View SEC Filing  
4/20/2016Bruce F JohnsonDirectorBuy500$2.88$1,440.00407,315View SEC Filing  
4/7/2016Bruce F JohnsonDirectorBuy200$2.82$564.00407,215View SEC Filing  
3/31/2016Bruce F JohnsonDirectorBuy600$3.01$1,806.00406,905View SEC Filing  
3/28/2016Bruce F JohnsonDirectorBuy100$3.03$303.00406,405View SEC Filing  
3/23/2016Bruce F JohnsonDirectorBuy720$2.76$1,987.20406,305View SEC Filing  
3/18/2016Bruce F JohnsonDirectorBuy500$2.85$1,425.00405,585View SEC Filing  
3/14/2016Bruce F JohnsonDirectorBuy500$2.96$1,480.00405,085View SEC Filing  
3/9/2016Bruce F JohnsonDirectorBuy500$2.94$1,470.00404,585View SEC Filing  
3/4/2016Lewis H Titterton JrDirectorBuy500$3.31$1,655.00497,437View SEC Filing  
3/1/2016Amit KumarDirectorBuy2,000$2.46$4,920.00103,408View SEC Filing  
2/29/2016Lewis H Titterton JrDirectorBuy2,000$2.29$4,580.00496,937View SEC Filing  
10/29/2015Henry P. HermsCFOSell3,500$3.78$13,230.0022,625View SEC Filing  
9/25/2015Amit KumarDirectorBuy1,000$4.70$4,700.00102,408View SEC Filing  
9/3/2015Bruce F JohnsonDirectorBuy2,000$3.95$7,900.00401,085View SEC Filing  
7/31/2015Bruce F JohnsonDirectorBuy3,050$5.15$15,707.50View SEC Filing  
7/24/2015Lewis H Titterton JrDirectorBuy7,000$5.47$38,290.00View SEC Filing  
7/22/2015Bruce F JohnsonDirectorBuy1,500$5.99$8,985.00View SEC Filing  
7/21/2015Amit KumarDirectorBuy5,000$5.69$28,450.00View SEC Filing  
7/20/2015Lewis H Titterton JrDirectorBuy4,400$5.46$24,024.00View SEC Filing  
6/23/2015Bruce F JohnsonDirectorBuy175,000$0.16$28,000.00View SEC Filing  
6/22/2015Amit KumarDirectorBuy100,000$0.15$15,000.00View SEC Filing  
6/22/2015Robert Andrew BermanCEOBuy80,000$0.15$12,000.00View SEC Filing  
6/19/2015Lewis H Titterton JrDirectorBuy280,000$0.13$36,400.00View SEC Filing  
6/18/2015Robert Andrew BermanCEOBuy130,000$0.13$16,900.00View SEC Filing  
6/17/2015Amit KumarDirectorBuy150,000$0.14$21,000.00View SEC Filing  
6/12/2015Bruce F JohnsonDirectorBuy50,000$0.15$7,500.00View SEC Filing  
6/11/2015Robert Andrew BermanCEOBuy25,000$0.14$3,500.00View SEC Filing  
6/10/2015Amit KumarDirectorBuy150,000$0.14$21,000.00View SEC Filing  
6/10/2015Robert Andrew BermanCEOBuy20,000$0.14$2,800.00View SEC Filing  
6/9/2015Lewis H Titterton JrDirectorBuy42,000$0.14$5,880.00View SEC Filing  
6/5/2015Bruce F JohnsonDirectorBuy36,000$0.14$5,040.00View SEC Filing  
6/4/2015Amit KumarDirectorBuy25,000$0.16$4,000.00View SEC Filing  
6/4/2015Robert Andrew BermanCEOBuy20,000$0.16$3,200.00View SEC Filing  
6/3/2015Lewis H Titterton JrDirectorBuy70,000$0.15$10,500.00View SEC Filing  
6/2/2015Amit KumarDirectorBuy100,000$0.14$14,000.00View SEC Filing  
6/1/2015Robert Andrew BermanCEOBuy30,000$0.14$4,200.00View SEC Filing  
4/6/2015Amit KumarDirectorBuy50,000$0.16$8,000.00View SEC Filing  
4/2/2015Bruce F JohnsonDirectorBuy10,000$0.16$1,600.00View SEC Filing  
4/1/2015Bruce F JohnsonDirectorBuy206,544$0.15$30,981.60View SEC Filing  
3/25/2015Bruce F JohnsonDirectorBuy155,000$0.14$21,700.00View SEC Filing  
3/23/2015Lewis H Titterton JrDirectorBuy245,000$0.10$24,500.00View SEC Filing  
3/23/2015Robert Andrew BermanCEOBuy100,000$0.11$11,000.00View SEC Filing  
3/18/2015Lewis H Titterton JrDirectorBuy110,000$0.09$9,900.00View SEC Filing  
3/24/2014Lewis H Titterton JrDirectorBuy100,000$0.28$28,000.00View SEC Filing  
1/31/2014Amit KumarDirectorBuy60,000$0.40$24,000.00View SEC Filing  
1/30/2014Bruce F JohnsonDirectorBuy15,000$0.40$6,000.00View SEC Filing  
1/29/2014Bruce F JohnsonDirectorBuy60,000$0.33$19,800.00View SEC Filing  
1/29/2014John H RoopVPBuy129,500$0.35$45,325.00View SEC Filing  
1/29/2014Robert Andrew BermanCEOBuy72,805$0.33$24,025.65View SEC Filing  
1/28/2014Amit KumarDirectorBuy120,800$0.30$36,240.00View SEC Filing  
1/24/2014Bruce F JohnsonDirectorBuy60,000$0.28$16,800.00View SEC Filing  
1/24/2014Robert Andrew BermanCEOBuy8,500$0.30$2,550.00View SEC Filing  
1/23/2014Bruce F JohnsonDirectorBuy120,000$0.28$33,600.00View SEC Filing  
1/22/2014Bruce F JohnsonDirectorBuy100,000$0.23$23,000.00View SEC Filing  
1/22/2014Robert Andrew BermanCEOBuy45,000$0.22$9,900.00View SEC Filing  
1/21/2014Lewis H Titterton JrDirectorBuy100,000$0.21$21,000.00View SEC Filing  
1/21/2014Robert Andrew BermanCEOBuy25,000$0.21$5,250.00View SEC Filing  
9/9/2013Henry P HermsCFOSell92,450$0.21$19,414.50View SEC Filing  
5/21/2013Bruce F JohnsonDirectorBuy24,973$0.30$7,491.90View SEC Filing  
5/16/2013Bruce F JohnsonDirectorBuy25,000$0.31$7,750.00View SEC Filing  
9/20/2012Bruce F JohnsonDirectorBuy6,000$0.20$1,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

ITUS (NASDAQ ITUS) News Headlines

Source:
DateHeadline
Is ITUS Corporation (NASDAQ:ITUS) Overpaying Its CEO?Is ITUS Corporation (NASDAQ:ITUS) Overpaying Its CEO?
finance.yahoo.com - December 19 at 11:12 AM
BRIEF-Itus Corporation Terminates At-The-Market OfferingBRIEF-Itus Corporation Terminates At-The-Market Offering
www.reuters.com - December 12 at 3:55 PM
ITUS Corporation Terminates At-The-Market OfferingITUS Corporation Terminates At-The-Market Offering
finance.yahoo.com - December 12 at 11:51 AM
ValuEngine Lowers ITUS (ITUS) to SellValuEngine Lowers ITUS (ITUS) to Sell
www.americanbankingnews.com - December 9 at 5:08 PM
ITUS Corp Expected to Earn FY2017 Earnings of ($0.58) Per Share (ITUS)ITUS Corp Expected to Earn FY2017 Earnings of ($0.58) Per Share (ITUS)
www.americanbankingnews.com - December 8 at 6:44 AM
ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC SymposiumITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium
finance.yahoo.com - December 6 at 11:33 AM
SeeThruEquity Initiates Coverage on ITUS Corporation (NASDAQ: ITUS) with a Price Target of $5.00SeeThruEquity Initiates Coverage on ITUS Corporation (NASDAQ: ITUS) with a Price Target of $5.00
finance.yahoo.com - December 5 at 12:52 PM
ITUS Corporation (ITUS): Should The Recent EPS Drop Worry You?ITUS Corporation (ITUS): Should The Recent EPS Drop Worry You?
finance.yahoo.com - December 4 at 11:34 AM
ITUS Receives Notice of Allowance for Second Key Cancer Technology PatentITUS Receives Notice of Allowance for Second Key Cancer Technology Patent
finance.yahoo.com - November 28 at 9:45 AM
BRIEF-Itus enters into 2-year collaboration agreementBRIEF-Itus enters into 2-year collaboration agreement
www.businessinsider.com - November 24 at 5:02 PM
How Moffitt could play a role in finding a treatment for ovarian cancerHow Moffitt could play a role in finding a treatment for ovarian cancer
finance.yahoo.com - November 23 at 2:34 AM
ITUS Conference Call Recording Available on Company WebsiteITUS Conference Call Recording Available on Company Website
www.prnewswire.com - November 22 at 7:37 AM
ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics ProgramITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program
finance.yahoo.com - November 21 at 8:18 PM
ITUS Enters CAR-T Research Alliance with Moffitt Cancer CenterITUS Enters CAR-T Research Alliance with Moffitt Cancer Center
finance.yahoo.com - November 21 at 1:05 AM
What Investors Should Know About ITUS Corporation’s (ITUS) Financial StrengthWhat Investors Should Know About ITUS Corporation’s (ITUS) Financial Strength
finance.yahoo.com - November 18 at 2:55 AM
BRIEF-ITUS Corp licenses CAR-T technology from Wistar InstituteBRIEF-ITUS Corp licenses CAR-T technology from Wistar Institute
www.reuters.com - November 15 at 3:25 AM
Wall Street Set for Weaker Open After Fed Speakers, DataWall Street Set for Weaker Open After Fed Speakers, Data
www.nasdaq.com - November 15 at 3:25 AM
ITUS Corporation (ITUS) Announces Agreement to License CAR-T Technology from The Wistar InstituteITUS Corporation (ITUS) Announces Agreement to License CAR-T Technology from The Wistar Institute
www.streetinsider.com - November 15 at 3:25 AM
ITUS Corporation Licenses CAR-T Technology from The Wistar InstituteITUS Corporation Licenses CAR-T Technology from The Wistar Institute
finance.yahoo.com - November 15 at 3:25 AM
ITUS Corporation Pays Off Secured DebentureITUS Corporation Pays Off Secured Debenture
finance.yahoo.com - October 28 at 7:14 AM
ITUS Corporation (ITUS) Sees Large Decline in Short InterestITUS Corporation (ITUS) Sees Large Decline in Short Interest
www.americanbankingnews.com - October 28 at 2:26 AM
BRIEF-ITUS Corp files for stock shelf offering of up to $24 mlnBRIEF-ITUS Corp files for stock shelf offering of up to $24 mln
www.reuters.com - October 17 at 5:41 AM
ITUS Corporation Discusses Early Cancer Detection Technology and new CAR-T, Ovarian Cancer Initiative in New SNNLive Video Interview with StockNewsNow.comITUS Corporation Discusses Early Cancer Detection Technology and new CAR-T, Ovarian Cancer Initiative in New SNNLive Video Interview with StockNewsNow.com
finance.yahoo.com - October 16 at 7:31 PM
ITUS Corporation (ITUS) Short Interest UpdateITUS Corporation (ITUS) Short Interest Update
www.americanbankingnews.com - October 13 at 1:58 AM
BRIEF-Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stockBRIEF-Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stock
www.reuters.com - September 29 at 5:12 PM
ITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK CapitalITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital
finance.yahoo.com - September 25 at 9:31 AM
ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian CancerITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer
finance.yahoo.com - September 22 at 1:43 PM
ITUS Skyrockets on Patent AwardITUS Skyrockets on Patent Award
www.baystreet.ca - September 20 at 9:29 PM
Todays Research Reports on Stocks to Watch: Itus Corporation and Nabriva TherapeuticsToday's Research Reports on Stocks to Watch: Itus Corporation and Nabriva Therapeutics
finance.yahoo.com - September 19 at 8:04 PM
BRIEF-Itus Corporation announces issuance of patent on cancer detection technologyBRIEF-Itus Corporation announces issuance of patent on cancer detection technology
www.reuters.com - September 19 at 12:32 AM
ITUS Corporation Announces Issuance of Patent on Cancer Detection TechnologyITUS Corporation Announces Issuance of Patent on Cancer Detection Technology
finance.yahoo.com - September 18 at 7:32 PM
ITUS Corp. :ITUS-US: Earnings Analysis: Q3, 2017 By the Numbers : September 12, 2017ITUS Corp. :ITUS-US: Earnings Analysis: Q3, 2017 By the Numbers : September 12, 2017
finance.yahoo.com - September 12 at 4:52 PM
ITUS Corporation Provides Company Overview and Discusses the Cchek(TM) Platform in New SNNLive Video Interview with StockNewsNow.comITUS Corporation Provides Company Overview and Discusses the Cchek(TM) Platform in New SNNLive Video Interview with StockNewsNow.com
finance.yahoo.com - August 9 at 8:31 PM
BRIEF-Itus Corp and Wistar Institute renew collaborative research agreementBRIEF-Itus Corp and Wistar Institute renew collaborative research agreement
www.reuters.com - August 8 at 5:30 AM
The Wistar Institute and ITUS Corporation Renew Collaborative Research AgreementThe Wistar Institute and ITUS Corporation Renew Collaborative Research Agreement
finance.yahoo.com - August 7 at 7:29 PM
Lew Titterton re-joins ITUS Corporations Board of DirectorsLew Titterton re-joins ITUS Corporation's Board of Directors
finance.yahoo.com - July 18 at 9:57 PM
ITUS names new CEOITUS names new CEO
seekingalpha.com - July 8 at 11:52 AM
BRIEF-Itus Corp appoints Dr. Amit kumar as new CEOBRIEF-Itus Corp appoints Dr. Amit kumar as new CEO
www.reuters.com - July 8 at 11:52 AM
ITUS Appoints Dr. Amit Kumar as New CEO and Announces Management ChangesITUS Appoints Dr. Amit Kumar as New CEO and Announces Management Changes
finance.yahoo.com - July 8 at 11:52 AM
Mid-Morning Market Update: Markets Open Lower; Macys Profit Misses ExpectationsMid-Morning Market Update: Markets Open Lower; Macy's Profit Misses Expectations
www.nasdaq.com - May 11 at 3:17 PM
ITUS launches public offering of common stock at $1.05; shares down 38%ITUS launches public offering of common stock at $1.05; shares down 38%
seekingalpha.com - May 11 at 3:17 PM
BRIEF-ITUS Corp prices public offering of up to 3.5 mln sharesBRIEF-ITUS Corp prices public offering of up to 3.5 mln shares
www.reuters.com - May 11 at 3:17 PM
BRIEF-ITUS Corp announces proposed public offering of common stockBRIEF-ITUS Corp announces proposed public offering of common stock
www.reuters.com - May 11 at 7:14 AM
ITUS Corporation (ITUS) Announces Share Offering; Proceeds for Working Capital, Debt Repayment, General PurposesITUS Corporation (ITUS) Announces Share Offering; Proceeds for Working Capital, Debt Repayment, General Purposes
www.streetinsider.com - May 11 at 7:14 AM
BRIEF-Itus changes record date for current stock rights offering to March 1BRIEF-Itus changes record date for current stock rights offering to March 1
www.reuters.com - February 11 at 4:51 AM
ITUS (ITUS) Presents at Noble Financial Capital Markets 13th Annual Small Cap and Emerging Growth Investor Conference-SlideshowITUS (ITUS) Presents at Noble Financial Capital Markets 13th Annual Small Cap and Emerging Growth Investor Conference-Slideshow
seekingalpha.com - February 1 at 11:51 PM
ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Prostate CancerITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Prostate Cancer
us.rd.yahoo.com - January 30 at 10:37 AM
ITUS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsITUS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
us.rd.yahoo.com - January 19 at 7:46 PM
ITUS CORP Files SEC form 10-K/A, Annual ReportITUS CORP Files SEC form 10-K/A, Annual Report
biz.yahoo.com - December 8 at 6:36 PM
ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study ResultsITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results
us.rd.yahoo.com - December 7 at 10:32 AM

SEC Filings

ITUS (NASDAQ:ITUS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ITUS (NASDAQ:ITUS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ITUS (NASDAQ ITUS) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.